Skip to main content
Clinical Trials/RBR-4vzrfyf
RBR-4vzrfyf
Recruiting
Phase 1

Effect of cardiopulmonary rehabilitation protocol on functionality, respiratory muscle e strength, perioheral and quality of life in patients recovered from COVID-19: a controlled and randomizes clinical study

Hospital Otávio de Freitas0 sitesJanuary 26, 2022

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Coronavirus infection of unspecified location
Sponsor
Hospital Otávio de Freitas
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 26, 2022
End Date
December 31, 2022
Last Updated
2 years ago
Study Type
Intervention

Investigators

Sponsor
Hospital Otávio de Freitas

Eligibility Criteria

Inclusion Criteria

  • Patients with at least six weeks after the clinical diagnosis of COVID\-19, admitted and participating in the post COVID\-19 cardiopulmonary rehabilitation protocol; Over 18 years of age; Both sexes; Presence of symptoms such as dyspnea, fatigue and functional impairment after recovery from COVID\-19

Exclusion Criteria

  • Active stage of the disease; Inability to understand and execute commands; Osteoarticular and/or muscle deficit that does not allow walking or with limits to the implementation of the established protocol; Patient diagnosed with lung diseases such as Chronic Obstructive Pulmonary Disease (COPD), Asthma, Cystic Fibrosis, Post Tuberculosis Pulmonary Disease, among others; Patients who have absolute contraindications to perform the six\-minute walk test (6MWT) which include the presence of unstable angina, uncontrolled systemic arterial hypertension, recent pulmonary embolism and heart attack that occurred in the month prior to the exam; Patients who drop out of treatment or have no 03 missing

Outcomes

Primary Outcomes

Not specified

Similar Trials